Evidence map›Paper›PMID 38110104›Full record

ReviewInternational journal of radiation oncology, biology, physics2024

Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials.

Heng Li, Nina A Mayr, Robert J Griffin, Hualin Zhang, Damodar Pokhrel, Michael Grams, Jose Penagaricano, Sha Chang, Matthew B Spraker, James Kavanaugh and 10 more

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06980259 narecruitingnot on this mapstarted 2025, after this paper: background citation

Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma:A Multicenter,Prospective, Phase II, Randomized Controlled Trial

TypeinterventionalSponsorShandong Cancer Hospital and InstituteRan2025 to 2028Enrolled106ConditionsSoft Tissue Sarcoma (STS)ArmsSpatially Fractionated Radiotherapy, Conventional Radiotherapy
NCT07744074 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Single-Arm Phase I Clinical Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Malignant Tumors

TypeinterventionalSponsorJi YonglingRan2026 to 2028Enrolled12ConditionsCarbon Ion RadiotherayArmsCarbon ion - Lattice radioIon Lattice Radiation Therapy for Thoracic bulky solid tumors
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Feasibility, safety, and clinical outcomes analysis of dense-lattice radiation therapy in palliative care for cancer patients´.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 2 countries.

Heng LiDepartment of Radiation Oncology, John Hopkins University, Baltimore, Maryland. Electronic address: hengli@jhu.edu.
Nina A MayrCollege of Human Medicine, Michigan State University, East Lansing, Michigan.
Robert J GriffinDepartment of Radiation Oncology, University of Arkansas for Medical Science, Little Rock, Arkansas.
Hualin ZhangDepartment of Radiation Oncology, University of Southern California, Los Angeles, California.
Damodar PokhrelDepartment of Radiation Medicine, University of Kentucky, Lexington, Kentucky.
Michael GramsDepartment of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
Jose PenagaricanoDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Sha ChangDepartment of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.
Matthew B SprakerCentura Health, Denver, Colorado.
James KavanaughDepartment of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
Liyong LinDepartment of Radiation Oncology, Emory University, Atlanta, Georgia.
Khadija SheikhDepartment of Radiation Oncology, John Hopkins University, Baltimore, Maryland.
Sina MossahebiDepartment of Radiation Oncology, University of Maryland, Baltimore, Maryland.
Charles B SimoneDepartment of Radiation Oncology, New York Proton Center, New York, New York.
David RobergeDepartment of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
James W SniderSouth Florida Proton Therapy Institute, 5280 Linton Blvd, Delray Beach, Florida.
Pouya SabouriDepartment of Radiation Oncology, University of Arkansas for Medical Science, Little Rock, Arkansas.
Andrea MolineuDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ying XiaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Stanley H BenedictDepartment of Radiation Oncology, University of California, Davis, Sacramento, California.
Mayo Clinic · USUniversity of Arkansas for Medical Sciences · USCentre Hospitalier de l’Université de Montréal · CAEmory University · USJohns Hopkins University · USMichigan State University · USMoffitt Cancer Center · USNew York Proton Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Davis · USUniversity of Kentucky · USUniversity of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USUniversity of Southern California · US

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

purposeThe highly heterogeneous dose delivery of spatially fractionated radiation therapy (SFRT) is a profound departure from standard radiation planning and reporting approaches. Early SFRT studies have shown excellent clinical outcomes. However, prospective multi-institutional clinical trials of SFRT are still lacking. This NRG Oncology/American Association of Physicists in Medicine working group consensus aimed to develop recommendations on dosimetric planning, delivery, and SFRT dose reporting to address this current obstacle toward the design of SFRT clinical trials. METHODS AND MATERIALS: Working groups consisting of radiation oncologists, radiobiologists, and medical physicists with expertise in SFRT were formed in NRG Oncology and the American Association of Physicists in Medicine to investigate the needs and barriers in SFRT clinical trials.

resultsUpon reviewing the SFRT technologies and methods, this group identified challenges in several areas, including the availability of SFRT, the lack of treatment planning system support for SFRT, the lack of guidance in the physics and dosimetry of SFRT, the approximated radiobiological modeling of SFRT, and the prescription and combination of SFRT with conventional radiation therapy.

conclusionsRecognizing these challenges, the group further recommended several areas of improvement for the application of SFRT in cancer treatment, including the creation of clinical practice guidance documents, the improvement of treatment planning system support, the generation of treatment planning and dosimetric index reporting templates, and the development of better radiobiological models through preclinical studies and through conducting multi-institution clinical trials.

Indexed as

Dose Fractionation, RadiationRadiotherapy Planning, Computer-AssistedClinical Trials as TopicConsensusHumansMulticenter Studies as TopicNeoplasmsProspective StudiesRadiation OncologyRadiobiology

Identifiers

PMID38110104
PMCPMC11162930
OpenAlexW4389839968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.